Should a Suspicious Armpit Node Be Biopsied First?
At a Glance
A suspicious armpit lymph node in breast cancer is usually evaluated with ultrasound, followed by an image-guided needle biopsy when it remains concerning and the result could change treatment. The result can affect how far the cancer has spread, surgery, and whether treatment starts before surgery.
In this answer
2 sections
Often, but not always. If a lymph node in your armpit (axilla) looks suspicious on imaging or feels abnormal, a biopsy is frequently recommended before you begin treatment—but primarily if the result could change your care plan [1][2][3].
Because cancers in the upper-outer quadrant of the breast naturally drain lymphatic fluid toward the axillary lymph nodes, your care team will want to know if cancer cells have traveled there. While the location of your tumor doesn’t automatically mean it has spread, confirming whether a lymph node is involved can significantly influence your cancer staging, the order in which you receive treatments, the type of axillary surgery you need, and your radiation therapy plan [4].
However, a biopsy is not mandatory for every patient. Your breast care team will decide based on your tumor’s biology, your planned treatment, and whether the biopsy result will actually alter your care.
How Suspicious Nodes are Evaluated
When a lymph node might be involved, axillary ultrasound (an imaging test using sound waves) is the preferred way to take a closer look [1][2][3]. It is important to tell your team if you’ve recently had a vaccination, infection, or skin inflammation, as these benign (non-cancerous) events can sometimes temporarily enlarge axillary nodes.
If the ultrasound confirms that a node remains suspicious in the context of your breast cancer, the next step is typically an image-guided needle biopsy, where a doctor uses the ultrasound to precisely guide a needle into the node to remove a small sample of tissue or cells for testing [2][3].
There are two main types of needle biopsy:
- Core-needle biopsy (CNB): Uses a hollow needle to remove a small cylinder of tissue.
- Fine-needle aspiration (FNA): Uses a very thin needle to withdraw cells or fluid.
When these tests find cancer, the result is highly reliable (meaning false alarms are very rare) [5][6][7]. However, they can sometimes miss cancer if it is present in very small amounts. A core-needle biopsy is generally better at successfully detecting cancer when it is present, though the choice between CNB and FNA depends on your specific lymph node, local medical expertise, and the type of tests your doctors need to run on the sample [6][5][7].
What to Expect During a Biopsy
A needle biopsy is an outpatient procedure. You will receive local anesthesia to numb the area, so you should only feel brief pressure or mild discomfort. Afterward, you might experience some soreness or bruising. Minor bleeding can occur, but severe bleeding or infection is uncommon. If you take blood thinners, be sure to ask your care team for instructions beforehand.
What the Results Mean for Your Treatment
If the Biopsy is Positive
A positive result means cancer cells were found in the sampled node. Knowing this before treatment begins allows your care team to tailor your therapy.
Depending on your tumor’s specific biology (such as hormone receptor and HER2 status), the size of the tumor, and the extent of node involvement, finding cancer in a lymph node might lead to a recommendation for neoadjuvant therapy (systemic treatments like chemotherapy, targeted therapy, or immunotherapy given before surgery) [4][8]. However, this is not automatic; some patients still have surgery first. The decision is highly individualized.
If your biopsy is positive and you are planning to receive neoadjuvant therapy, the doctor performing the biopsy will likely place a tiny metallic clip (or marker) inside that specific lymph node [4][8]. After your pre-surgery treatments are finished, your surgeon can use a localization method (like a wire or a seed) to find that clip and remove that exact node. This allows them to see if the treatment successfully destroyed the cancer cells [9][10]. This targeted removal is often done alongside a sentinel lymph node biopsy (removing the first few nodes cancer is most likely to spread to) and is called a Targeted Axillary Dissection (TAD). TAD can significantly improve the accuracy of staging after neoadjuvant therapy for selected patients [9][10][11].
If the Biopsy is Negative
A negative needle biopsy result means no cancer was found in the sample, but it does not guarantee the lymph node is completely free of cancer. False-negative results can happen, especially if the cancer in the node is very small [12][13][14].
Because of this risk, your doctors will evaluate whether the biopsy result makes sense given how the node looked on the ultrasound [15]. If the node looks highly abnormal on ultrasound but the needle biopsy shows no cancer, your team may recommend a repeat biopsy or rely on further surgical staging (like a sentinel lymph node biopsy) at the time of your breast surgery to check for cancer spread [16][17][13]. In some cases, if the evaluation is reassuring, additional node surgery may be minimized or avoided, depending on the overall surgical plan.
Common questions in this guide
Does every suspicious armpit lymph node in breast cancer need a biopsy?
What test is used first for a suspicious axillary lymph node?
Is a core biopsy better than a fine-needle aspiration for an axillary node?
What can a positive axillary lymph node biopsy change?
Why might a clip be placed in a biopsied lymph node?
What happens if my axillary lymph node biopsy is negative?
What should I expect during an armpit lymph node needle biopsy?
One line in your results can change your plan.
A needle biopsy of a suspicious armpit node is mainly recommended if the result could change the treatment plan. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on female breast upper-outer quadrant cancer.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.
Marino MA, Avendano D, Zapata P, et al.
The oncologist 2020; (25(2)):e231-e242 doi:10.1634/theoncologist.2019-0427.
PMID: 32043792 - 2
Axillary Imaging Following a New Invasive Breast Cancer Diagnosis-A Radiologist's Dilemma.
Dialani V, Dogan B, Dodelzon K, et al.
Journal of breast imaging 2021; (3(6)):645-658 doi:10.1093/jbi/wbab082.
PMID: 38424939 - 3
To Look or Not to Look? Axillary Imaging: Less May Be More.
Mango VL, Pilewskie M, Jochelson MS
Journal of breast imaging 2021; (3(6)):666-671 doi:10.1093/jbi/wbab075.
PMID: 38424931 - 4
Targeting and limiting surgery for patients with node-positive breast cancer.
Caudle AS, Kuerer HM
BMC medicine 2015; (13()):149 doi:10.1186/s12916-015-0385-5.
PMID: 26109042 - 5
The accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph nodes in women with breast cancer: a systematic review and meta-analysis.
Zheng H, Zhao R, Wang W, et al.
Frontiers in oncology 2023; (13()):1166035 doi:10.3389/fonc.2023.1166035.
PMID: 37416528 - 6
Meta-analysis of the diagnostic accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph node metastasis.
Balasubramanian I, Fleming CA, Corrigan MA, et al.
The British journal of surgery 2018; (105(10)):1244-1253 doi:10.1002/bjs.10920.
PMID: 29972239 - 7
Diagnostic Accuracy of Fine-Needle Aspiration Cytology and Core-Needle Biopsy in the Assessment of the Axillary Lymph Nodes in Breast Cancer-A Meta-Analysis.
Pyo JS, Jung J, Lee SG, et al.
Diagnostics (Basel, Switzerland) 2020; (10(9)) doi:10.3390/diagnostics10090717.
PMID: 32962089 - 8
Intermediary clip placement to assist accurate axillary lymph node localization.
Price ER, Vyas S, Lee AY, et al.
Clinical imaging 2021; (73()):96-100 doi:10.1016/j.clinimag.2020.11.042.
PMID: 33352497 - 9
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
Caudle AS, Yang WT, Krishnamurthy S, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(10)):1072-8 doi:10.1200/JCO.2015.64.0094.
PMID: 26811528 - 10
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
Boughey JC, Ballman KV, Le-Petross HT, et al.
Annals of surgery 2016; (263(4)):802-7 doi:10.1097/SLA.0000000000001375.
PMID: 26649589 - 11
The Evolving Role of Marked Lymph Node Biopsy (MLNB) and Targeted Axillary Dissection (TAD) after Neoadjuvant Chemotherapy (NACT) for Node-Positive Breast Cancer: Systematic Review and Pooled Analysis.
Swarnkar PK, Tayeh S, Michell MJ, Mokbel K
Cancers 2021; (13(7)) doi:10.3390/cancers13071539.
PMID: 33810544 - 12
Determinants of False-Negative Fine-Needle Aspirates of Axillary Lymph Nodes in Women with Breast Cancer: Lymph Node Size, Cortical Thickness and Hilar Fat Retention.
Ewing DE, Layfield LJ, Joshi CL, Travis MD
Acta cytologica 2015; (59(4)):311-4 doi:10.1159/000440797.
PMID: 26422248 - 13
False-negative rate of ultrasound-guided fine-needle aspiration cytology for identifying axillary lymph node metastasis in breast cancer patients.
Kane G, Fleming C, Heneghan H, et al.
The breast journal 2019; (25(5)):848-852 doi:10.1111/tbj.13402.
PMID: 31197915 - 14
Pre-operative axillary ultrasound with fine-needle aspiration cytology performance and predictive factors of false negatives in axillary lymph node involvement in early breast cancer.
Hotton J, Salleron J, Henrot P, et al.
Breast cancer research and treatment 2020; (183(3)):639-647 doi:10.1007/s10549-020-05830-z.
PMID: 32737710 - 15
Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
Nakamura R, Yamamoto N, Miyaki T, et al.
Breast cancer (Tokyo, Japan) 2018; (25(1)):86-93 doi:10.1007/s12282-017-0795-7.
PMID: 28735457 - 16
Axillary Ultrasound: For All, for None, to Diagnose Positive Nodes, or to Support Avoiding Sentinel Lymph Node Biopsy Altogether.
Black D
Annals of surgical oncology 2017; (24(1)):64-69 doi:10.1245/s10434-016-5499-2.
PMID: 27557827 - 17
Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients.
Riedel F, Schaefgen B, Sinn HP, et al.
European journal of radiology 2021; (135()):109468 doi:10.1016/j.ejrad.2020.109468.
PMID: 33338758
This page is for informational purposes only and does not constitute medical advice about whether your suspicious axillary node should be biopsied. Your breast care team can interpret your imaging and recommend the safest plan for you.